“Off-label” can sound like a red flag, but in dermatology it’s often the most practical way to treat real people with real problems. Dr. Trotter sits down with board-certified dermatologist Dr. Victoria Farley to explain what FDA approval actually means, why many effective skin treatments never get a specific label, and how we talk through safety, side effects, and expectations – so patients feel confident rather than confused.

We walk through concrete examples you may recognize from your own care: spironolactone for hormonal acne and androgen-related conditions, finasteride and dutasteride considerations for women, and why low-dose oral minoxidil can be a game-changer when topical routines are hard to keep up with. We also cover a classic “wait, why does my prescription mention cancer?” moment with topical 5-FU, and how that same medication can be used off label for stubborn plantar warts with thoughtful counseling and monitoring.

From there, we zoom out to what’s next in medical dermatology: GLP-1 drugs and their emerging connection to inflammatory skin disease like psoriasis and hidradenitis suppurativa, plus the rapidly expanding world of JAK inhibitors for immune-mediated conditions including lichen planus, lichen sclerosus, granuloma annulare, and more. We also dig into chronic itch, especially in older adults, and why antihistamines are not always the best long-term answer, with off-label options like naltrexone and gabapentin entering the conversation.

If you’ve ever wondered whether off-label prescribing is legal, ethical, or worth it, this conversation gives you a clear framework: evidence, experience, and a patient-specific risk-benefit plan, plus the reality of insurance coverage and prior authorizations. Subscribe for more practical dermatology education, share this with a friend who’s navigating a confusing prescription, and leave a review with the off-label question you want answered next.

DISCLAIMER: The views and opinions expressed in the Derm-it Trotter! podcast are those of the host and guests and do not necessarily reflect the views or positions of the guests’ or host’s institution or employers. The Derm-it Trotter! Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.

Your hair can feel like a small thing until cancer treatment threatens to take it away. We sit down with board-certified hematologist-oncologist Dr. Tiffany Pompa to talk honestly about chemotherapy hair loss, why it happens, and why the emotional impact is often underestimated by everyone except the people living it. We also dig into how immunotherapy differs, why hair loss is usually uncommon with many immunotherapy regimens in real practice, and where the published numbers can be confusing without context.

From there, we get practical about scalp cooling and cold cap therapy: who benefits most, when to start, and what to expect on infusion days. Dr. Pompa explains why taxane chemotherapy such as paclitaxel and docetaxel is a common setting for scalp cooling, especially in breast cancer, gynecologic cancers like ovarian cancer, and lung cancer. We walk through the three FDA-approved systems DigniCap, Paxman, and AMA, including the real-life routine of wearing the cap before, during, and after treatment, plus the most common side effects like headaches, intense cold, and rare frostbite.

Access matters as much as science, so we talk insurance coverage, cost, and advocacy. Dr. Pompa shares how she argues medical necessity, why NCCN guidelines help, what Medicare and Medicaid approval in 2026 changes, and how state legislation can expand coverage. We also discuss manual frozen gel cap options like Penguin caps for patients who need a more affordable workaround, along with the tradeoffs. If you or someone you love is starting chemo, this conversation gives you language, options, and a clear next step: ask early. Subscribe, share this with someone who needs it, and leave a review so more patients and clinicians learn that hair loss prevention is part of quality cancer care.

Dark spots can be frustrating, especially when they seem to stick around despite your best efforts. Dr. Heather Woolery-Lloyd joins us to break down what causes hyperpigmentation, the differences between melasma, post-inflammatory hyperpigmentation, and sunspots, and how dermatologists approach treatment.

We discuss the role of sunscreen, visible light, hydroquinone alternatives, chemical peels, and evidence-based skincare ingredients that can help fade discoloration. If you're tired of guessing what works, this episode offers a practical roadmap to treating hyperpigmentation more effectively.

You can feel the tension the moment a patient says, “I want that medication.” From SkinTok trends to viral skincare advice, dermatologist Dr. Jim Del Rosso joins us from the AOCD meeting to break down how dermatologists navigate treatment requests while still building trust. We talk about acne, rosacea, topical steroid fears, antibiotic resistance, and why the right diagnosis matters more than chasing internet trends.

We also unpack the communication skills that actually improve outcomes, from setting realistic skincare timelines to explaining systemic treatments for eczema in a less intimidating way. If you’ve ever felt overwhelmed by conflicting skincare advice or frustrated that products are not working fast enough, this episode brings the focus back to evidence-based care that actually works.

Chronic hives can hijack your sleep, focus, mood, and confidence, and the hardest part is often not knowing why it’s happening. Board-certified dermatologist and Northwestern associate professor Dr. Walter Liszewski joins us to break down the biggest myths around urticaria, explain the difference between acute and chronic hives, and walk through common patterns like dermatographism, pressure hives, heat-triggered flares, and exercise-induced hives.

We also get practical about treatment: when allergy testing actually helps, why Benadryl and steroids are not great long-term solutions, and how newer therapies like omalizumab, dupilumab, and remibrutinib are changing care for people stuck in the chronic hives cycle.

Joint pain with psoriasis is easy to brush off until it starts affecting your daily life. We sit down with Mark Lebwohl to break down the early warning signs of psoriatic arthritis, from nail pitting and heel pain to swollen “sausage” fingers and morning stiffness. We also explain how doctors diagnose it, why it is often mistaken for osteoarthritis, and why catching it early matters.

We also unpack the rapidly changing treatment landscape, including biologics that protect joints and improve skin disease, plus the major role inflammation and obesity play in worsening symptoms. If you have psoriasis and unexplained aches or swelling, this episode gives you a clear roadmap for what to watch for and what questions to ask next.

A biopsy is still the gold standard for diagnosing skin cancer, but it is far from perfect. From the AOCD meeting in Orlando, Dr. Laura Ferris, Chair of Dermatology at the University of North Carolina, joins us to break down how skin cancer detection is evolving and why tools like dermoscopy, mole mapping, and total body photography are changing the way dermatologists evaluate suspicious lesions.

We also explore the growing role of AI and FDA-cleared technologies like Nevisense and Dermasensor, plus the challenges of access to dermatology care, especially in rural communities. From smarter screening to reducing unnecessary biopsies, this episode looks at what the future of skin cancer detection could really look like.

Insurance denials are one of the most frustrating parts of modern healthcare, and in dermatology, they can delay medically necessary treatment for weeks or even months. Recorded live from the AOCD meeting in Florida, board-certified dermatologist Dr. Kristi Hawley joins us to explain what’s really happening behind prior authorizations, PBMs, formulary restrictions, and “peer-to-peer” reviews.

We talk about the real impact these delays have on patients living with eczema, psoriasis, and other inflammatory skin diseases, along with what patients can actually do to advocate for themselves. If you’ve ever been told your medication “isn’t covered,” this episode breaks down why and what happens next.

Squamous cell carcinoma is the skin cancer most people shrug off until it stops playing by the rules. From the AOCD meeting in Orlando, I sit down with board-certified dermatologist and Mohs surgeon Dr. Carlos Gomez Mead to talk about why cutaneous squamous cell carcinoma can be far more dangerous than its reputation and why, on a population level, it can lead to more deaths than melanoma.

We dig into what actually makes a squamous cell carcinoma “high risk” in real life: rapid growth, pain with pressure that can hint at perineural invasion, and high risk head and neck locations where lymphatic spread is a real concern. We also talk candidly about the shortcomings of common staging systems (NCCN, AJCC, and BWH) and why clinical judgment still matters when cancer behavior is unpredictable.

Then we get practical about gene expression profiling for squamous cell carcinoma, including DecisionDx-SCC (a 40-gene test run on the original biopsy tissue). Dr. Gomez Mead breaks down results in plain language: low, medium, and high risk, and how those categories can change what we do next, from imaging surveillance and oncology collaboration to when adjuvant radiation therapy may actually help. We also spend time on immunosuppressed patients, especially transplant recipients, and why proactive planning can be lifesaving.

If you care about skin cancer prevention, early detection, and smarter personalized treatment, hit subscribe, share this with a friend, and leave a review so more people can find the show.

Acne can feel mysterious until you zoom out and see the pattern: your skin is responding to signals from blood sugar, hormones, inflammation, stress, and even your environment. Dr. Shannon C. Trotter sits down with board-certified dermatologist Dr. Katie Varman of Shine Functional Dermatology to unpack what’s happening under the surface, and why treating acne is often about finding your biggest driver rather than hunting for a single “bad” ingredient. 

We dig into the science linking insulin to acne, including how frequent high-glycemic foods can activate growth pathways (including mTOR and insulin-like growth factor signaling) that increase oil production and pore-clogging skin buildup. We also talk dairy and why it can be a powerful trigger for some people, plus how a continuous glucose monitor (CGM) can help you personalize what actually spikes your blood sugar. If you’ve ever wondered why one person can eat pizza and be fine while another breaks out overnight, we explain the “threshold” concept and how to test changes without living on a permanent restriction plan. 

From there, we connect the dots on gut health and the gut microbiome, probiotics and postbiotics, and why processed foods can quietly undermine skin health. We also get real about stress and acne, breaking down the HPA axis, cortisol, and how your skin can behave like an endocrine organ. Finally, we cover endocrine disrupting chemicals like phthalates and BPA, why synthetic fragrance is a common exposure, and simple swaps that can reduce your load without panic. 

If you want clearer skin and a smarter acne routine, hit play, then subscribe, leave a review, and share the show with someone who needs a little skincare sanity.